APA (7th ed.) Citation

von Tresckow, J., Heyl, N., Robrecht, S., Giza, A., Aldaoud, A., Schlag, R., . . . Fink, A. M. (2023). Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group. Annals of Hematology, 102(11), 3083. https://doi.org/10.1007/s00277-023-05314-2

Chicago Style (17th ed.) Citation

von Tresckow, Julia, et al. "Treatment with Idelalisib in Patients with Chronic Lymphocytic Leukemia – Real World Data from the Registry of the German CLL Study Group." Annals of Hematology 102, no. 11 (2023): 3083. https://doi.org/10.1007/s00277-023-05314-2.

MLA (9th ed.) Citation

von Tresckow, Julia, et al. "Treatment with Idelalisib in Patients with Chronic Lymphocytic Leukemia – Real World Data from the Registry of the German CLL Study Group." Annals of Hematology, vol. 102, no. 11, 2023, p. 3083, https://doi.org/10.1007/s00277-023-05314-2.